There are four scheduled IPOs for the following week. One company will see its 25-day underwriter research quiet period end. There will be no scheduled 180-day shareholder sale lockup expirations.

There are no IPOs scheduled for the coming week. Two firms will see their 25-day underwriter research quiet period end. There are five 180-day shareholder sale lockup period expirations expected ...